about
Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patientsNeuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathwaysNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsMild cognitive impairment: diagnosis, longitudinal course, and emerging treatmentsDesigner Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer's Disease via Enhancing Neuron Differentiation and Paracrine Action.Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.Genetically modified pig models for neurodegenerative disorders.Intranasal administration of acetylcholinesterase inhibitors.Altered subcellular distribution of c-Abl in Alzheimer's disease.Update on the pharmacological treatment of Alzheimer's diseaseDivalent cation tolerance protein binds to β-secretase and inhibits the processing of amyloid precursor protein.Structure-activity relationships for a series of compounds that inhibit aggregation of the Alzheimer's peptide, Aβ42Ameliorative effects of a combination of baicalin, jasminoidin and cholic acid on ibotenic acid-induced dementia model in rats.Treatment of Essential Tremor: Are there Issues We are Overlooking?Potential repurposing of oncology drugs for the treatment of Alzheimer's disease.Genetics of Alzheimer's disease: a centennial reviewOvine colostrum nanopeptide affects amyloid beta aggregation.Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugsEfficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathyPreparing a persian version of kimberley indigenous cognitive assessment for assessing the cognitive problems of illiterate geriatric patients.DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effectsDevelopment of dual inhibitors against Alzheimer's disease using fragment-based QSAR and molecular docking.Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid.Curcumin Protects β-Lactoglobulin Fibril Formation and Fibril-Induced Neurotoxicity in PC12 Cells.Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's diseaseTherapeutic Effect of Yi-Chi-Tsung-Ming-Tang on Amyloid β-Induced Alzheimer's Disease-Like Phenotype via an Increase of Acetylcholine and Decrease of Amyloid β.Impact of amyloid imaging on drug development in Alzheimer's disease.Dendrobium alkaloids prevent Aβ25-35-induced neuronal and synaptic loss via promoting neurotrophic factors expression in miceNeurochemical biomarkers in Alzheimer's disease and related disorders.Present and prospective clinical therapeutic regimens for Alzheimer's disease.Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease PathologyA review on primary progressive aphasia.Genetic aspects of Alzheimer diseaseEarly diagnosis and treatment of Alzheimer's disease.Current concepts in Alzheimer's disease: a multidisciplinary review.Recent advances in hydrogen research as a therapeutic medical gas.Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective.Huprines for Alzheimer's disease drug development.
P2860
Q22251259-8A7F8FF0-5CD0-4858-8C4B-B6B73312BBDDQ26779424-05F0A75D-084F-41BD-9EBE-728AAF0BF789Q26866006-50834909-15D0-4B9F-B6B0-C62B42CBA0CAQ27026362-5AE21F75-664E-4B2B-8E9B-80EE7A1FAF9FQ27345382-8E189A75-11E5-4909-B8B6-26F497BA84A2Q30368281-22F9C19A-4D82-45E4-B1F5-88173381FB38Q31002975-324952E8-A3DD-4EFE-AF32-27FF60088B29Q33393915-C2C441CC-68A1-4F67-AF6E-9FF651FBF0D3Q33429538-B168F2A8-38CD-40F1-BA56-1F9948563912Q33836947-81096FB4-88D1-47B8-A269-897411477D97Q34094449-20B58B74-54BF-4BC4-AEE0-87A6EA677DB1Q34338974-D21D3545-F1E8-42E2-9998-E66A0DBADAC7Q34599205-B4578742-BB3B-4A0C-86C8-7632E17873CFQ34635365-E28CEEE8-56DE-4623-B6B8-83C017A77A91Q34636891-11E0D9E6-3100-48E3-A79B-AC53936E64F4Q34656812-F12E45FE-1FD4-40A5-89ED-372CAD6C13F0Q34904386-9372642C-8B43-450D-A0EC-E63CDAF30F0DQ34911093-5C680968-26BE-47EA-9B30-BF52D4EE1904Q34973787-6A40068B-3174-4264-9C5E-0CDF6678D6AEQ34990904-16667921-5F0F-4AE7-AD70-3270E26F82E9Q35053868-922D63A4-1C68-4744-B359-AE2B45B241C2Q35206199-2E3128A3-5411-4878-82BB-353253EAD9CFQ35311113-8CB58EDD-1724-4411-AC8E-7A2A012C19CFQ35694684-91AA4832-E92F-44D4-BBED-DE516D408E10Q36026890-297980CC-0DA9-4F5F-B994-CB15514B4AE3Q36056174-DBD83C50-1506-4EED-A06F-99E5BBB96116Q36144632-48AFBC36-422C-4253-901A-C9CEB4D42CE5Q36229080-4C39FE27-8892-4DCC-9780-D630F8D3B27AQ36366891-6166C8CE-104C-434E-9261-47FE8461AEE8Q36876447-6DA6C7D9-A5F0-4C9D-B10F-4F277A89D1A3Q37053850-AFF397E9-D1DF-4616-9F73-1F441074662DQ37129799-698526AD-B1B0-4B2C-B6D3-5DB0D5AC6EC4Q37139063-693C0886-8CAE-4F87-B354-8665F6E26184Q37154809-DEEF7AC0-9FA6-464E-A32C-B4277A666DDAQ37360292-552962D1-6CCD-4674-A042-4A5DDCF5208BQ37785099-072C7CA5-3BB1-4401-94B1-579DBDC8AEA9Q37912199-BAA72D6A-283B-4868-89EB-11DD10D6E728Q38000337-FDFA06D8-79AE-4F31-AE1F-EEC12615F5EEQ38052929-B245D89A-3E9B-4E05-8365-C607181F786FQ38088283-194310AE-CC16-4CBA-8C55-6FDBE36AF609
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapeutic approaches to Alzheimer's disease
@ast
Therapeutic approaches to Alzheimer's disease
@en
Therapeutic approaches to Alzheimer's disease
@nl
type
label
Therapeutic approaches to Alzheimer's disease
@ast
Therapeutic approaches to Alzheimer's disease
@en
Therapeutic approaches to Alzheimer's disease
@nl
prefLabel
Therapeutic approaches to Alzheimer's disease
@ast
Therapeutic approaches to Alzheimer's disease
@en
Therapeutic approaches to Alzheimer's disease
@nl
P356
P1433
P1476
Therapeutic approaches to Alzheimer's disease
@en
P2093
H.-W. Klafki
M. Staufenbiel
P304
P356
10.1093/BRAIN/AWL280
P407
P577
2006-09-29T00:00:00Z